Education

• MD, Medical School of Munich, 1973
• PhD, University of Munich, Germany, 1975
• Fellowship, Immunobiology Research, University of Wisconsin Hospital and Clinics, Madison, WI, 1975-1976
• Residency, University of Wisconsin Hospital and Clinics, Madison, WI, 1976-1980

Professional Activities

Dr. Sollinger is on the editorial board of several international academic journals, including Transplantation and the Journal of the American College of Surgeons.
He holds offices for the following national and international professional societies:

• American Society of Transplant Surgeons (past-president)
• International Society of Organ Sharing (past-president)
• The Transplantation Society (treasurer)

Clinical Specialties

Dr. Sollinger is certified by the American Board of Surgery. He specializes in kidney and pancreas transplantation as well as total pancreatectomy and islet autotransplantation as a treatment for chronic pancreatitis.

Dr. Sollinger provides a wide range of services including Kidney Transplant, Pancreas Transplant, and Pediatric Kidney Transplant.

Research Interests

Dr. Sollinger’s research interests include the clinical and preclinical testing of new immunosuppressive agents and gene therapy for cell transplantation.

Active Clinical Trials

• A Partially Blinded, Prospective, Randomized Multicenter Study Evaluating Efficacy, Safety and Tolerability of Oral Sotrastaurin Plus Standard or Reduced Exposure Tacrolimus vs. Mycophenolic Acid Plus Tacrolimus in de Novo Renal Transplant Recipients
  Principal Investigator(s): Hans W. Sollinger, MD, PhD, FACS
  Status: Active, not recruiting
  [ClinicalTrials.gov: NCT01064791]
  More Information
• Mycophenolic Acid Monotherapy in Recipients of HLA-identical Living-Related Transplantation
  Principal Investigator(s): William J Burlingham, PhD, Hans W. Sollinger, MD, PhD, FACS
  Status: Active, not recruiting
  [ClinicalTrials.gov: NCT01053221]
  More Information

Recent Publications

• Differential outcomes of expanded-criteria donor renal allografts according to recipient age.
  Mezrich JD, Pirsch JD, Fernandez LA, Foley DP, Bellingham JM, Odorico JS, Leverson GE, Munoz-Del-Rio A, Sollinger HW, Kaufman DB, D'Alessandro AM
  Clin J Am Soc Nephrol 2012 Jul; 7(7):1163-71.
  [PubMed ID: 22653256, PMC ID: 3386667]
  More Information
• Alemtuzumab as compared to alternative contemporary induction regimens.
  LaMattina JC, Mezrich JD, Hofmann RM, Foley DP, D'Alessandro AM, Sollinger HW, Pirsch JD
  Transpl. Int. 2012 May; 25(5):518-26.
  [PubMed ID: 22394259]
  More Information
• Pretransplant immune regulation predicts allograft outcome: bidirectional regulation correlates with excellent renal transplant function in living-related donor-recipient pairs.
  Jankowska-Gan E, Sheka A, Sollinger HW, Pirsch JD, Hofmann RM, Haynes LD, Armbrust MJ, Mezrich JD, Burlingham WJ
  Transplantation 2012 Feb 15; 93(3):283-90.
  [PubMed ID: 22186938, PMC ID: 3366360]
  More Information
• The impact of hepatitis C virus donor and recipient status on long-term kidney transplant outcomes: University of Wisconsin experience.
  Singh N, Neidlinger N, Djamali A, Leverson G, Voss B, Sollinger HW, Pirsch JD
  Clin Transplant 2012 Sep-Oct; 26(5):684-93.
  [PubMed ID: 22283142]
  More Information
• Long-term pancreatic allograft survival after renal retransplantation in prior simultaneous pancreas-kidney recipients.
  Lamattina J, Sollinger H, Becker Y, Mezrich J, Pirsch J, Odorico J
  Am. J. Transplant. 2012 Apr; 12(4):937-46.
  [PubMed ID: 22233437]
  More Information